Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease.

Key Points

• This research aims to explore the connection between type 2 diabetes treatment status and Alzheimer’s disease biomarkers.
• Analyzed the association between diabetes treatment and amyloid beta (Aβ) deposition.
• Examined in vivo biomarkers for Alzheimer's disease in individuals with varying diabetes treatment status.
• Untreated type 2 diabetes is associated with early amyloid beta deposition.
• Treated type 2 diabetes does not show the same association with amyloid burden.